News

Shea butter, aloe vera, olive oil: three natural ingredients when your skin craves simple soothing Moisturizing one's skin is an essential step in preserving its suppleness and encouraging its ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...
She was the beloved mother of Jean (Al) Neves, Patricia (Tim) Murphy, and Paula (Brian) O’Shea. She was the sister of the late, Masako Matsuo. Marie was a caring and loving person to all.
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
There are few companies with a story as exciting as Vertex’s. In 1912, Claude Lyons — a bright, ingenious businessman who had been working in the watch trade since he was 17-year-old — established the ...